Major Subject Dates: After today's Mathematics paper, major subjects like English (Feb 21), Science (Feb 25), and Social Science (March 7) follow in quick succession. The March 3 Update: Students ...
Download CBSE Class 10 Important Questions and Answers 2026 for Maths, Science, SST, English & Hindi in PDF format. Practise with expert-curated, chapter-wise questions with detailed solutions based ...
Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for subcutaneous amivantamab and hyaluronidase-lpuj as ...
LUND, Sweden, Feb. 18, 2026 /PRNewswire/ — Hansa Biopharma AB, (“Hansa” or “the Company”), (Nasdaq Stockholm: HNSA), today announced that its Biologics License Application (BLA) for imlifidase has ...
New designation is based on data showing rapid and durable responses in a heavily pretreated patient population and expands the promise of RYBREVANT FASPRO beyond lung ...
Opinion
Decades of Warnings, Persistent Inaction: Studies Raise New Alarms on Psychiatric Drug Safety
Safety signals spanning decades have not removed many high-risk psychiatric drugs from the market, prompting renewed scrutiny of federal regulators ...
With the CBSE Class 12 Accountancy exam approaching, students are advised to focus on revising key topics like partnership accounts, company accounts, cash flow statements, and ratios. Practicing ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min This is the third group of ...
The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD).
If approved, imlifidase will be the first treatment to address highly sensitized patients awaiting kidney transplantation. LUND, Sweden, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results